Page 2 - Prime Editor News Today

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped up prior to trading on Wednesday following insider buying activity. The stock had previously closed at $8.03, but opened at $8.59. Prime Medicine shares last traded at $8.34, with a volume of 55,245 shares changing hands. Specifically, Director Robert Nelsen bought 3,200,000 shares of […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $8.03, but opened at $8.59. Prime Medicine shares last traded at $8.34, with a volume of 55,245 shares. Specifically, Director Robert Nelsen bought 3,200,000 shares of the […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price fell 6.4% during trading on Tuesday . The company traded as low as $6.89 and last traded at $7.01. 78,928 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 523,514 shares. The stock had previously closed at $7.49. […]

Greenwich Wealth Management LLC boosted its position in shares of Prime Medicine, Inc. (NYSE:PRME – Free Report) by 111.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 439,021 shares of the company’s stock after buying an additional 231,021 shares during the period. Greenwich […]

Prime Medicine, Inc. (PRME.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Prime Medicine, Inc. | Nasdaq: PRME | Nasdaq

Presenter SpeechEric Joseph Good afternoon. Im Eric Joseph, senior biotech analyst with JPMorgan. Our next presenting company this afternoon is Prime Medicines. And presenting on behalf of the...

Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $9.01, but opened at $8.78. Prime Medicine shares last traded at $8.67, with a volume of 26,036 shares trading hands. Wall Street Analyst Weigh In Several research firms recently issued reports […]

Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price […]

Investment analysts at Citigroup initiated coverage on shares of Prime Medicine (NYSE:PRME – Get Free Report) in a research report issued on Friday, Marketbeat.com reports. The brokerage set a “neutral” rating and a $10.00 price target on the stock. Citigroup’s target price points to a potential upside of 17.65% from the stock’s previous close. Several […]

Prime Medicine (NYSE:PRME – Get Free Report) is one of 288 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Prime Medicine to similar companies based on the strength of its earnings, valuation, institutional ownership, risk, analyst recommendations, profitability and dividends. Insider and Institutional […]